Somatostatin receptor imaging in patients with neuroendocrine tumors: Not only SPECT?

Journal of Nuclear Medicine

Volumn 48, Issue 4, 2007, Pages 498-500

  Schillaci, Orazio ^a,b  

^a University Tor Vergata ^*  (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 5 HYDROXYTRYPTOPHAN; DEXTRO PHENYLALANYLTYROSINE OCTREOTIDE; DOPA; GALLIUM 68; HYDRAZINONICOTINYL TYROSINE OCTREOTIDE; N ALPHA (1 DEOXY DEXTRO FRUCTOSYL) NEPSILON (2 18 F FLUOROPROPIONYL) LYSYLTYROSINE OCTREOTATE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION; GASTROINTESTINAL TUMOR; METABOLISM; METHODOLOGY; NOTE; NUCLEAR MEDICINE; PATHOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RADIOMETRY; TIME;

GASTROINTESTINAL NEOPLASMS; HUMANS; NEUROENDOCRINE TUMORS; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34248596145     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.038653     Document Type: Short Survey

References (19)

1. 3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508-518.
2. Solcia E, Klöppel G, Sobin LH. Histological typing of endocrine tumours. In: Solcia E, Klöppel G, Sobin LH, eds. International Histological Classification of Tumours. 2nd ed. Berlin, Germany: Springer-Verlag; 2000:61-68.
3. Gibril F, Jensen RT. Diagnostic uses of radio-labelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. Dig Liver Dis. 2004;36(suppl 1):S106-S120.
4. Ricke J, Klose KJ, Mignon M, Oberg K, Wiedenmann B. Standardisation of imaging in neuroendocrine tumours: results of a European delphi process. Eur J Radiol. 2001;37:8-17.
5. Dromain C, de Baere T, Lumbroso J, et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol. 2005;23:70-78.
6. Schillaci O, Scopinaro F, Angeletti S, et al. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med. 1996;37:1452-1456.
7. Schillaci O. Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biother Radiopharm. 2004;19:129-134.
8. Krausz Y, Israel O. Single-photon emission computed tomography/computed tomography in endocrinology. Semin Nucl Med. 2006;36:267-274.
9. Adams S, Baum R, Rink T, et al. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med. 1998;25:79-83.
10. 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg. 1998;22:588-592.
11. Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2006;36:228-247.
12. 68Ga-Labeled peptides in tumor imaging. J Nucl Med. 2005;46(suppl 1):172S-178S.
13. 68Ga. Eur J Nucl Med Mol Imaging. 2005;32:478-485.
14. 111In]DTPA- octreotide. J Nucl Med. 2006;47:566-573.
15. 68Ga-DOTATOC: preliminary data. Eur J Nucl Med. 2001;28:1751-1757.
16. 111In]-DTPAOC SPECT: first results in patients with neuroendocrine tumors. Mol Imaging Biol. 2003;5:42-48.
17. Eriksson B, Orlefors H, Oberg K, Sundin A, Bergstrom M, Langstrom B. Developments in PET for the detection of endocrine tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:311-324.
18. Sundin A, Eriksson B, Bergstrom M, Langstrom B, Oberg K, Orlefors H. PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci. 2004;1014:246-257.
19. 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging. 2006;33:460-466.